Consistent with a role for IL-38 in suppressing lung cancer, overexpression of IL-38 suppressed NSCLC development in vivo and increased the sensitivity to chemotherapeutic drugs. This evidence concerns the gene IL1F10 and non-small cell lung carcinoma.